Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Sales of Property, Plant and Equipment (2010 - 2026)

Analysis

Bio-Rad Laboratories (BIO) Sales of Property, Plant and Equipment (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 4.00 Mn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn -
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn -
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 3.04 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn -
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -100,000.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -100,000.00
Mar 31, 2026 100,000.00
Jun 30, 2025 100,000.00
Jun 30, 2024 74,000.00
Mar 31, 2024 26,000.00
Dec 31, 2023 96,000.00
Sep 30, 2023 65,000.00
Jun 30, 2023 39,000.00
Dec 31, 2022 86,000.00
Sep 30, 2022 6,000.00
Jun 30, 2022 108,000.00
Sep 30, 2021 39,000.00
Jun 30, 2021 1,000.00
Mar 31, 2021 12,000.00
Dec 31, 2020 19,000.00
Sep 30, 2020 18,000.00
Jun 30, 2020 -5,000.00
Mar 31, 2020 38,000.00
Dec 31, 2019 44,000.00
Sep 30, 2019 -1,000.00